In 2016, we published an article on the dangers of the meningitis B vaccination, Bexsero, titled, Are Ineffective New Meningitis B Vaccines Causing Harm to Children?
At the time of publication, according to the FDA product information leaflet, the vaccine had in fact only been approved for children over the age of ten.
Despite, this fact however, in the UK, the meningitis B vaccine Bexsero was being administered to infants as young as 2 months, despite the fact that we could find no evidence to support that this vaccine was safe to be administered to babies.
In our previous article, we stated that:
“In the UK, Bexsero is the main vaccination being recommended for babies between the ages of two and six months, a vaccine that, according to the manufacturers vaccine insert, has only been approved for individuals from the ages of 10 through to 25.”